Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are predicting strong results driven by the robust https://louiseonuo099668.ampedpages.com/analyzing-eli-lilly-s-q3-results-63857929